Non-Interventional Observational Study With Viramune Plus ARV in HIV Infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2015
At a glance
- Drugs Nevirapine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/abacavir; Lamivudine/zidovudine
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 09 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov.
- 07 Mar 2012 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.